Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans - Wikidata - thesis-toulmin - TriplyDB

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans

http://www.wikidata.org/entity/Q21144945

about

A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications FRMD3 gene: its role in diabetic kidney disease. A narrative review Insights into the genetic architecture of diabetic nephropathy Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures Complement factor H gene associations with end-stage kidney disease in African Americans.Family-based association analysis confirms the role of the chromosome 9q21.32 locus in the susceptibility of diabetic nephropathy Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans Kidney transplantation in a low-resource setting: Nigeria experience.Comparative analysis of methods for detecting interacting loci.Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.Familial clustering of ESRD in the Norwegian population Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa.APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Target organ damage in African American hypertension: role of APOL1.Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)The new era of APOL1-associated glomerulosclerosis.Urinary biomarkers of kidney diseases in HIV-infected children.Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy.The challenging search for diabetic nephropathy genes Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants.HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy Understanding the epigenetic syntax for the genetic alphabet in the kidney The expanding family of FERM proteins.Molecular disease presentation in diabetic nephropathy.Hypertension-attributed nephropathy: what's in a name?Genetic epidemiology in kidney disease.rs1888747 polymorphism in the FRMD3 gene, gene and protein expression: role in diabetic kidney disease.APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.The renal archaeologist: digging for clues in archived tissues to understand diabetic kidney disease.Diabetic nephropathy: FRMD3 in diabetic nephropathy--guilt by association.Concepts of Genomics in Kidney Transplantation.Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.APOL1 variants and kidney disease in people of recent African ancestry.

P2860

Q26769678-024B020C-6FC3-4A04-9C1E-E246DD308806 Q26771495-3ED0B19B-BB0A-429D-9CDD-464284235B15 Q26823352-B2CFB0F1-1612-4020-8048-6DD52DE873C4 Q28391758-59EFCB32-2B10-4B40-AF13-CFC901AFBEC2 Q30384517-AE2572E4-81A1-4ACD-AD67-B208C02A1CEF Q30420116-11FC1ED0-E1ED-48AF-8206-90EAFE19CDA6 Q33623998-E9244E02-A5F2-4F42-A14F-556CCF9947C9 Q33873191-FF9E6B70-9BA2-46E6-AA03-2CB06E4C7830 Q33950989-591EA1A0-9492-4A81-A422-65068D2DFF88 Q34008876-BC2643A8-D2E6-43B5-BC0E-B9F94D828EC8 Q34292853-FD8A8E38-3B7D-40A9-9168-2A8E573EF307 Q34455119-1AD11570-CEC5-435B-A5D5-1EA8B7DE269C Q34534055-2C701326-30B0-41F0-BBCA-9DEFEC12AF17 Q34540191-E6510BA8-B69E-45DD-B384-269A22EDA672 Q35097336-0369F462-E304-4FCA-8C32-92EF03734CDC Q35565624-65137759-A968-4701-AECD-DD4F9C83237B Q35658743-DF7DEEE4-3E4D-4CC4-B516-C1149D54C6E6 Q35754934-508B6DF6-65EC-4CF2-9491-0D0E5818DC5B Q35861466-BD51529D-C68D-475D-B91E-0D99923EE9BD Q35934081-8FB72466-6425-46D5-AB08-ED3B73D5D445 Q36109264-0AE1DF16-60F3-4796-8042-421EFB2847F4 Q36109292-4D2467B4-37E7-4625-85F3-19CD25CF9A16 Q36250613-9C62267C-A57B-4770-8A80-A5E48573C5F0 Q36252600-12CBC103-D96C-43E9-9985-49C623A37048 Q36294088-ED471273-24CB-45E6-AE55-2DD5762C9500 Q36366892-28E0D743-0B10-4F07-ABD2-EE5E25FCC901 Q37411672-D2EF5089-E90E-410A-9CF4-AC2ED691141F Q38105599-D4242E0A-7C9F-4D23-99D4-EEDCCE776039 Q38460161-6796DFB0-A79C-43F1-9651-C037A06A4477 Q38629320-E3C3BA97-7280-476B-8D2E-677D6106F616 Q38757142-2065F797-62D1-400F-A971-3275ED422C6B Q41964720-BB464434-378D-4187-AB62-E9C1B1336BDB Q42417122-D8DAF81E-6387-481C-AA3C-E52A7C376785 Q42672940-D967F411-DB25-464A-8D03-2AB4B26D88F0 Q43156352-8DD909D3-CA67-4F5D-AEB9-5B6F45BE7BA7 Q43654924-A9F0401D-7AAB-4E96-8B05-1BA21E4DE107 Q46684824-B5F11FA0-CF01-4A0B-BCEE-FF1E8C3C1786 Q46737437-AE960FC9-9F7E-413C-BFF2-C4DB2C531311 Q50183550-DD6E4865-E55B-44B4-930F-EC0E5B21C051 Q51492603-7A36FB8C-A030-4FD6-A440-5FB2F666E086

P2860

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans

http://www.wikidata.org/entity/Q21144945

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Differential effects of MYH9 a ...... etic ESRD in African Americans

@ast

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en-gb

Differential effects of MYH9 a ...... etic ESRD in African Americans

@nl

type

label

Differential effects of MYH9 a ...... etic ESRD in African Americans

@ast

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en-gb

Differential effects of MYH9 a ...... etic ESRD in African Americans

@nl

altLabel

Differential Effects of MYH9 a ...... etic ESRD in African Americans

@en

prefLabel

Differential effects of MYH9 a ...... etic ESRD in African Americans

@ast

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en-gb

Differential effects of MYH9 a ...... etic ESRD in African Americans

@nl

P1433

Q21144945-7CE8A791-19C6-4350-AE9D-93B52EB0C776

P1476

Q21144945-0F449250-48D7-4D4D-8F6F-0DEA1DF19CA5

P2093

Q21144945-14804FA1-BC82-4A10-AF85-51CDC1AFE506

Q21144945-1635FA77-9094-4E5C-B9AE-576E2E5A6506

Q21144945-19B08D21-47CA-4719-8DBF-6CFB1486CB05

Q21144945-1E951F5E-31B2-47EA-90DF-4C80C5E7DEC3

Q21144945-23102D21-EC1A-4B97-BB47-5CD9557BEFEC

Q21144945-2546CF87-9FF3-415A-9002-F327049AC8BF

Q21144945-2B66CD09-5069-48E8-AC21-756A34D74D94

Q21144945-344EE24A-0AD2-401F-8D53-3E7CF3C97736

Q21144945-4E4C66BA-F674-4A50-AA74-1663764A77A0

Q21144945-6284F0AA-343A-427E-A5EC-5AF2210C84AE

P2860

Q21144945-0B3AF050-0650-44C8-A4DC-2B351B98667B

Q21144945-13E37B36-A493-4BE6-A3E5-8BEA50BF2833

Q21144945-3416097E-F46D-43CA-952B-4E02C91768A2

Q21144945-35B01B5B-3BB1-4363-8B22-BA9F30ADF897

Q21144945-3E6BD6B1-137A-4362-A5CB-AB60C6BAFE90

Q21144945-4ADBBD9C-EF0E-453F-821D-4BC6547116D7

Q21144945-522F2C46-4934-4BF6-8F49-7D4A9969608B

Q21144945-54CFE989-5B3F-4CFB-8F89-32D21BAEAB33

Q21144945-69CB9349-1749-45CA-8CC2-8CA77C4114FB

Q21144945-7244394E-2C6A-498C-A6A4-B2E52E9013EE

P304

Q21144945-6C1B348D-0AE4-4CA7-B9E6-1A3FA446457E

P31

Q21144945-1259084A-B968-400A-BAC7-AB3426FFC2BC

P356

Q21144945-4DDB0DC1-FA4F-4A02-8522-44995ECA3185

P407

Q21144945-96F77ECC-C5B3-45CA-9A04-0F0328531BA8

P433

Q21144945-7A6FEAA1-94BA-480D-8D6F-732C47E671E2

P478

Q21144945-41864BB9-AA6E-4F37-A68E-54BE20008C9D

P50

Q21144945-129D0401-B26F-484E-A536-14CE760B3A6B

Q21144945-29A25915-6533-4887-898B-FB0C259BC1F8

P577

Q21144945-9E2D33D7-CD2D-481C-88ED-3B52C35F3FB8

P5875

Q21144945-224C32A5-054B-4A47-9AEC-E5E0EA8155C7

P698

Q21144945-70B2A422-0860-4DC3-911D-897C76006F9B

P932

Q21144945-C3800AF0-F8F1-4BB7-9EA2-101BB491FCCB

P356

JOURNAL.PGEN.1002150

P1433

P1476

Differential effects of MYH9 a ...... etic ESRD in African Americans

@en

P2093

Barry I Freedman

http://www.w3.org/2001/XMLSchema#string

Caitrin W McDonough

http://www.w3.org/2001/XMLSchema#string

Carl D Langefeld

http://www.w3.org/2001/XMLSchema#string

Cheryl A Winkler

http://www.w3.org/2001/XMLSchema#string

Donald W Bowden

http://www.w3.org/2001/XMLSchema#string

George W Nelson

http://www.w3.org/2001/XMLSchema#string

Jasmin Divers

http://www.w3.org/2001/XMLSchema#string

Jessica N Cooke

http://www.w3.org/2001/XMLSchema#string

Lingyi Lu

http://www.w3.org/2001/XMLSchema#string

Mary E Comeau

http://www.w3.org/2001/XMLSchema#string

P2860

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

New loci associated with kidney function and chronic kidney disease

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane

Multiple loci associated with indices of renal function and chronic kidney disease

A genome-wide association study for diabetic nephropathy genes in African Americans

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function.

P304

e1002150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PGEN.1002150

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey B. Kopp

Randall Johnson

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51243118

http://www.w3.org/2001/XMLSchema#string

P698

21698141

http://www.w3.org/2001/XMLSchema#string

P932

3116917

http://www.w3.org/2001/XMLSchema#string